HOME >> BIOLOGY >> NEWS
JCI table of contents, 15 October, 2003

n's Hospital, London, United Kingdom
Phone: +44-20-7905-2657
Fax: +44-20-7404-6191
Email: mdattani@ich.ucl.ac.uk

View the PDF of this article at: https://www.the-jci.org/press/18589.pdf


Antibodies fend off fungal respiratory infection

Histoplasma capsulatum is the most common cause of fungal respiratory infections in the world and poses a particular threat to the elderly and immunocompromised patients such as those with HIV or organ transplant recipients undergoing immunosuppressive drug therapy. Using a mouse model of histoplasmosis, Joshua Nosanchuk and colleagues from Albert Einstein College of Medicine in New York have identified monoclonal antibodies that targeted the histone H2B-like protein of H. capsulatum and reduced fungal burden, diminished inflammation, and prolonged host survival. While vaccine development for H. capsulatum is an exciting area of research, vaccination may not be effective in immunocompromised individuals. Therefore it is conceivable that this group of individuals may benefit from passive therapy with specific monoclonal antibodies to H. capsulatum, such as those described in this report.

TITLE: Antibodies to a cell surface histone-like protein protect against Histoplasma capsulatum

AUTHOR CONTACT:
Joshua D. Nosanchuk
Albert Einstein College of Medicine, New York, New York, USA.
Phone: (718) 430-3766
Fax 1: (718) 430-8701
E-mail: nosanchu@aecom.yu.edu

View the PDF of this article at: https://www.the-jci.org/press/19361.pdf



'"/>

Contact: Brooke Grindlinger
science_editor@the-jci.org
212-342-9006
Journal of Clinical Investigation
15-Oct-2003


Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related biology news :

1. Chemical engineering grad students will take notable national awards
2. New study indicates arsenic could be suitable as first-line treatment in type of leukaemia
3. JCI table of contents September 15, 2004
4. JCI table of contents: 1 September, 2004
5. Anti-cancer compound in vegetables found to block late-stage breast-cancer cell growth
6. JCI table of contents, 16 August, 2004
7. JCI table of contents, 2 August, 2004
8. When male fish hum, females swim in, thanks to hormones, adaptable hearing
9. JCI table of contents, 1 July 2004
10. Search and destroy protein turns tables on HIV
11. JCI table of contents, 15 June 2004

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/28/2020)... ... May 27, 2020 , ... CrucialTrak, a global designer ... New Jersey-based Critical Environments Group (CEG) to market and sell its complete line of ... center and IT environment infrastructure optimization solutions . , Brett Mason, CrucialTrak’s ...
(Date:5/28/2020)... ... May 28, 2020 , ... ... for adjunct liquefaction: AMYLEX® 6T. The innovative enzyme enables numerous business gains ... segments with locally-sourced raw materials, improve productivity, maximize yield, ensure consistent quality ...
(Date:5/26/2020)... , ... May 26, 2020 ... ... enterprise software solutions for biopharmaceutical R&D, today announced that Gritstone Oncology, Inc., ... receptor (TCR)-mimetic bispecific T cell engagers and TCR-based therapeutics, has implemented ...
Breaking Biology News(10 mins):
(Date:6/28/2020)... ... June 25, 2020 , ... With the ... vaccine or drug treatment. In an effort to better understand the cellular responses ... world’s largest imaging dataset portraying therapeutic compound effects from over 1,600 approved and ...
(Date:6/23/2020)... BOSTON (PRWEB) , ... June 23, 2020 , ... ... to facilitate access to unique lab-made bioresearch materials, today announced the availability of ... Michael Whitt laboratory at University of Tennessee, enables studies of SARS-CoV-2 viral entry ...
(Date:6/23/2020)... , ... June 22, 2020 , ... ... glutamine antagonist, DRP-104, will be presented June 22-24 during the American Association for ... DRP-104; and, the other profiles the potent, consistent single agent activity in KEAP1 ...
(Date:6/11/2020)... ... June 08, 2020 , ... Greffex, ... through the use of proprietary clean viral vectors, recently announced a key manufacturing ... Greffex’s platform is the world’s most successful gene therapy delivery vehicle (vector) ...
Breaking Biology Technology:
Cached News: